Cleared Traditional

K220337 - GaiaBone Bioabsorbable Bone Graft

K220337 is an FDA 510(k) clearance for GaiaBone Bioabsorbable Bone Graft, manufactured by Corliber (Shenzhen) Medical Device Co., Ltd.. The device is a Class 2 Orthopedic device with product code MQV cleared through the Traditional 510(k) pathway after a 361-day FDA review.

K220337 · Corliber (Shenzhen) Medical Device Co., Ltd. · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2023
Decision
361d
Days
Class 2
Risk

K220337 is an FDA 510(k) clearance for the GaiaBone Bioabsorbable Bone Graft. Classified as Filler, Bone Void, Calcium Compound (product code MQV), Class II - Special Controls.

Submitted by Corliber (Shenzhen) Medical Device Co., Ltd. (Shenzhen City, CN). The FDA issued a Cleared decision on February 3, 2023 after a review of 361 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3045 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Corliber (Shenzhen) Medical Device Co., Ltd. devices

FDA 510(k) Submission Details - K220337

510(k) Number K220337 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 07, 2022
Decision Date February 03, 2023
Days to Decision 361 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
239d slower than avg
Panel avg: 122d · This submission: 361d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MQV Device Classification - Class 2, Special Controls

Product Code MQV Filler, Bone Void, Calcium Compound
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3045
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Consultant

Cosmos Biomed Consulting Co., Ltd.
Li-Ting Lu

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - MQV Filler, Bone Void, Calcium Compound

All 291
Devices cleared under the same product code (MQV) and FDA review panel - the closest regulatory comparables to K220337.
Bonalive Orthopedics granules
K231528 · Bonalive Biomaterials, Ltd. · Jul 2023
Tactoset
K223915 · Anika Therapeutics, Inc. · Mar 2023
DSM Biomedical Calcium Phosphate Cement
K230054 · Dsm Biomedical · Mar 2023
MONTAGE Settable, Resorbable Bone Putty
K222063 · Orthocon, Inc. · Feb 2023
OsteoCNX
K223563 · Converg Engineering · Jan 2023
Uni-FuZe-C Bone Strip
K221726 · Zavation Medical Products, LLC · Jan 2023